Evidence map›Paper›PMID 28493964›Full record

ArticlePloS one2017

Non-human primate orthologues of TMPRSS2 cleave and activate the influenza virus hemagglutinin.

Pawel Zmora, Paulina Molau-Blazejewska, Stephanie Bertram, Kerstin Walendy-Gnirß, Inga Nehlmeier, Anika Hartleib, Anna-Sophie Moldenhauer, Sebastian Konzok, Susann Dehmel, Katherina Sewald and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 2 institutions in 1 country.

Pawel ZmoraInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Paulina Molau-BlazejewskaInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Stephanie BertramInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Kerstin Walendy-GnirßInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Inga NehlmeierInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Anika HartleibInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Anna-Sophie MoldenhauerInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Sebastian KonzokDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Susann DehmelDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Katherina SewaldDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Constantin BrinkmannInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.
Christoph CurthsDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Sascha KnaufPathology Unit, German Primate Center, Leibniz-Institute, Kellnerweg 4, Göttingen, Germany.
Jens GruberPrimate Genetics Laboratory, Junior Research Group "Medical RNA Biology," German Primate Center, Leibniz-Institute, Göttingen, Germany.
Kerstin Mätz-RensingPathology Unit, German Primate Center, Leibniz-Institute, Kellnerweg 4, Göttingen, Germany.
Franziska DahlmannDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Armin BraunDivision Preclinical Pharmacology and In Vitro Toxicology, Fraunhofer Institute for Toxicology and Experimental Medicine; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), Member of the German Center for Lung Research, Nikolai-Fuchs-Strasse 1, Hannover, Germany.
Stefan PöhlmannInfection Biology Unit, German Primate Center, Leibniz-Institute Kellnerweg 4, Göttingen, Germany.ORCID http://orcid.org/0000-0001-6086-9136
German Primate Center · DEFraunhofer Institute for Toxicology and Experimental Medicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cellular serine protease TMPRSS2, a member of the type II transmembrane serine protease (TTSP) family, cleaves and activates the hemagglutinin of influenza A viruses (FLUAV) in cell culture and is essential for spread of diverse FLUAV in mice. Non-human primates (NHP), in particular rhesus and cynomolgus macaques, serve as animal models for influenza and experimental FLUAV infection of common marmosets has recently also been reported. However, it is currently unknown whether the NHP orthologues of human TMPRSS2 cleave and activate FLUAV hemagglutinin and contribute to viral spread in respiratory tissue. Here, we cloned and functionally analyzed the macaque and marmoset orthologues of human TMPRSS2. In addition, we analyzed the macaque orthologues of human TMPRSS4 and HAT, which also belong to the TTSP family. We found that all NHP orthologues of human TMPRSS2, TMPRSS4 and HAT cleave and activate HA upon directed expression and provide evidence that endogenous TMPRSS2 is expressed in the respiratory epithelium of rhesus macaques. Finally, we demonstrate that a serine protease inhibitor active against TMPRSS2 suppresses FLUAV spread in precision-cut lung slices of human, macaque and marmoset origin. These results indicate that FLUAV depends on serine protease activity for spread in diverse NHP and in humans. Moreover, our findings suggest that macaques and marmosets may serve as models to study FLUAV activation by TMPRSS2 in human patients.

Indexed as

Sequence Homology, Amino AcidAmino Acid SequenceAnimalsConserved SequenceHEK293 CellsHemagglutinin Glycoproteins, Influenza VirusHumansInfluenza A virusLungMacaca mulattaPrimatesRespiratory MucosaSerine EndopeptidasesTransfectionHemagglutinin Glycoproteins, Influenza VirusSerine Endopeptidases

Identifiers

PMID28493964
PMCPMC5426610
OpenAlexW2613674576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.